Ocular toxicity of antimalarial drugs. Long-term follow-up.
D000293:Adolescent; D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects; D004585:Electrooculography; D004596:Electroretinography; D005128:Eye Diseases / Q000139:chemically induced*; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage / Q000009:adverse effects; D008027:Light; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008266:Macula Lutea / Q000187:drug effects; D008875:Middle Aged; D009887:Ophthalmoscopy; D011796:Quinacrine / Q000008:administration & dosage / Q000009:adverse effects; D012173:Retinitis / Q000139:chemically induced; D014787:Vision Tests; D014794:Visual Fields
D000962:Antimalarials; D006886:Hydroxychloroquine; D002738:Chloroquine; D011796:Quinacrine